Sharon Pelles-Avraham
Overview
Explore the profile of Sharon Pelles-Avraham including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
67
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Geva R, Gusev A, Polyakov Y, Liram L, Rosolio O, Alexandru A, et al.
Proc Natl Acad Sci U S A
. 2023 Aug;
120(33):e2304415120.
PMID: 37549296
Real-world healthcare data sharing is instrumental in constructing broader-based and larger clinical datasets that may improve clinical decision-making research and outcomes. Stakeholders are frequently reluctant to share their data without...
2.
Purim O, Beny A, Inbar M, Shulman K, Brenner B, Dudnik E, et al.
Target Oncol
. 2018 Jan;
13(2):217-226.
PMID: 29353436
Background: Precision treatment of cancer uses biomarker-driven therapy to individualize and optimize patient care. Objective: To evaluate real-life clinical experience with biomarker-driven therapy in metastatic gastric and esophageal cancer in...
3.
Safra T, Bernstein-Molho R, Greenberg J, Pelles-Avraham S, Stephansky I, Sarid D, et al.
Oncology
. 2011 Dec;
81(5-6):298-305.
PMID: 22156381
Objective: This study reports the efficacy and safety of zoledronic acid (ZOL) in preventing bone loss in postmenopausal patients receiving an aromatase inhibitor (AI) following tamoxifen. Methods: Postmenopausal patients with...
4.
Safra T, Borgato L, Nicoletto M, Rolnitzky L, Pelles-Avraham S, Geva R, et al.
Mol Cancer Ther
. 2011 Aug;
10(10):2000-7.
PMID: 21835933
Epithelial ovarian cancer (EOC) patients with BRCA mutations (BRCA +) benefit from platinum-based treatment more than noncarriers. Impaired ability to repair DNA by homologous recombination increases their chemosensitivity. We investigated...
5.
Cohen H, Jotkowitz A, Buskila D, Pelles-Avraham S, Kaplan Z, Neumann L, et al.
Eur J Intern Med
. 2006 Dec;
17(8):567-71.
PMID: 17142176
Background: High rates of psychiatric co-morbidity have been reported in patients with irritable bowel syndrome (IBS) and high rates of post-traumatic stress disorder (PTSD) have been reported in fibromyalgia, a...